Dr Leung’s research identifies and characterises key drivers involved in pathogenic thrombosis with the aim to develop better therapies. Dr Leung has published 9 research articles in the last 5 years in leading Q1 journals. Her research on immune thrombosis and the role of neutrophil activation such as NETosis in thrombosis has had notable reach and influence both nationally and internationally, as exemplified by her highly cited publications including a top 1% highly cited first author publication in Nature Communications. Dr Leung is also an investigator on 5 successful competitive research grants ($2.5M). As an inventor on 2 patents (covering 9 novel molecules for treatment of thrombotic disorders), she is actively engaged in meetings with UNSW Business Development Manager and pharmaceutical companies to advance her patented molecules to clinical trials. 

Since 2017, Dr Leung has been an organising committee member of the Research in Progress Meetings (RIPM) held at the St George & Sutherland Clinical Campus, UNSW. These seminars are a platform for researchers within the clinical school international collaborators and industry leaders, to present their research to an audience consisting of clinicians, medical students, scientists and members of the public.